Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma

NCT05536700 · clinicaltrials.gov ↗
UNKNOWN
Status
67
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators